6:33 PM
 | 
Jun 30, 2009
 |  BC Extra  |  Clinical News

Pfizer discontinues Sutent study

Pfizer Inc. (NYSE:PFE) said it discontinued the Phase III SUN 1122 trial to treat metastatic colorectal cancer...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >